首页> 外文期刊>International Journal of Ayurvedic Medicine >Clinical Evaluation of Panchavaktra Ras in the Management of Amavata (Rheumatoid Arthritis)
【24h】

Clinical Evaluation of Panchavaktra Ras in the Management of Amavata (Rheumatoid Arthritis)

机译:Panchavaktra Ras治疗Amavata(类风湿关节炎)的临床评价

获取原文
           

摘要

Objectives: This study was conducted to evaluate the effectiveness of Panchavaktra Ras in the Management of Amavata (Rheumatoid Arthritis). Materials and Methods: A single blind clinical trial was conducted at Dr. Achanta Lakshmipati Govt. Ayurvedic Hospital, M.G. Road, Vijayawada. 50 patients were selected and trial drug was advocated in a dose of 300 mg. (2 tablets) twice a day with Trikatu and Arka moola twak kashaya as anupana . Treatment was given for 45 days with the result assessment recorded at every 15 days. Subjective and objective parameters were analyzed before and after the treatment. In subjective parameters Sandhi Shula, Jadya, Angamarda, Alasya, Agnimandhya and Vidvibandha are taken, while Sandhi Shotha , Erythrocyte Sedimentation Rate (ESR) and R.A. Factor are considered as objective parameters. Results: It was observed that 48% were in mild relief group, while 50% were of moderate relief and there was Good relief in 2% of patients. Both Subjective and Objective parameters have been analyzed statistically. The relief of Sandhi Shula, Stabdata, Angimandya, Angamarda, Alasya and Vidvibandha found highly significant (P < 0.001) and same results in reduction Sandhi Shotha , ESR levels and RA Factor. Conclusion: Panchavaktra Ras prepared as per the textual standards is highly effective in Amavata and showing a way out to the individual suffering from this chronic disease. The study confirmed the effect of trial drug in Amavata (Rheumatoid arthritis) in improving the quality of life of patients without any untoward effects
机译:目的:本研究旨在评估Panchavaktra Ras在Amavata(类风湿关节炎)治疗中的有效性。材料和方法:Achanta Lakshmipati Govt博士进行了一项单盲临床试验。阿育吠陀医院路,维杰亚瓦达。选择了50名患者,并主张以300 mg的剂量使用试验药物。 (2片)每天两次,以Trikatu和Arka moola twak kashaya作为anupana。治疗进行了45天,每15天记录一次结果评估。治疗前后对主观和客观参数进行分析。在主观参数中,使用了Sandhi Shula,Jadya,Angamarda,Alasya,Agnimandhya和Vidvibandha,而使用了Sandhi Shotha,红细胞沉降率(ESR)和R.A.因子被视为客观参数。结果:观察到轻度缓解组中有48%,中度缓解组中有50%,2%的患者有良好的缓解。主观和客观参数均已进行统计分析。 Sandhi Shula,Stabdata,Angimandya,Angamarda,Alasya和Vidvibandha的缓解作用非常显着(P <0.001),减少Sandhi Shotha,ESR水平和RA因子的效果相同。结论:按照文本标准制备的Panchavaktra Ras在Amavata中非常有效,并向患有这种慢性疾病的个体显示了出路。该研究证实了在阿马瓦塔(类风湿关节炎)中使用试验药物对改善患者生活质量的作用,而没有任何不良影响

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号